^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    mammaglobin-A DNA vaccine

    i
    Associations
    News

    Trials

    Company:
    GSK, Washington University School of Medicine in St. Louis
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy (NCT02204098)
    Phase 1
    Washington University School of Medicine
    Active, not recruiting
    Last update posted :
    04/16/2024
    Initiation :
    01/07/2015
    Primary completion :
    04/06/2022
    Completion :
    08/31/2028
    HER-2 • SCGB2A2
    |
    HER-2 amplification • HER-2 negative
    |
    mammaglobin-A DNA vaccine